SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001437749-26-006387 from cbdMD, Inc. (YCBD)

cbdMD, Inc.
Date: March 2, 2026 · CIK: 0001644903 · Accession: 0001437749-26-006387

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-292869

Date
March 2, 2026
Author
/s/ T. Ronan Kennedy
Form
CORRESP
Company
cbdMD, Inc.

Letter

ycbd20260201_corresp.htm

cbdMD, Inc.

2101 Westinghouse Blvd., Suite A

Charlotte, NC 28273

March 2, 2026

Via EDGAR

Division of Corporation Finance

Securities and Exchange Commission

100 F Street, N.E.

Washington, D. C. 20549

Re:

cbdMD, Inc.

Registration Statement on Form S-1

File No. 333-292869

Ladies and Gentlemen:

In accordance with Rule 461 promulgated pursuant to the Securities Act of 1933, cbdMD, Inc. is hereby requesting that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:30 p.m. EST on March 4, 2026, or as soon thereafter as is practicable.

If you have any questions regarding this request, please contact either Brian Pearlman or Brian Bernstein, our legal counsel, at (561) 686-3307.

Very truly yours,
/s/ T. Ronan Kennedy

Show Raw Text
CORRESP
1
filename1.htm

	ycbd20260201_corresp.htm

cbdMD, Inc.

2101 Westinghouse Blvd., Suite A

Charlotte, NC 28273

March 2, 2026

Via EDGAR

Division of Corporation Finance

Securities and Exchange Commission

100 F Street, N.E.

Washington, D. C. 20549

			Re:

			cbdMD, Inc.

			Registration Statement on Form S-1

			File No. 333-292869

Ladies and Gentlemen:

In accordance with Rule 461 promulgated pursuant to the Securities Act of 1933, cbdMD, Inc. is hereby requesting that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:30 p.m. EST on March 4, 2026, or as soon thereafter as is practicable.

If you have any questions regarding this request, please contact either Brian Pearlman or Brian Bernstein, our legal counsel, at (561) 686-3307.

			Very truly yours,

			/s/ T. Ronan Kennedy

			T. Ronan Kennedy

			Chief Executive Officer and Chief Financial Officer

cc:

Brian A. Pearlman, Esq.

Brian S. Bernstein, Esq.